Browsing: Access2

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…

Background Heart failure (HF) is a significant health problem with a prevalence of 4.5% in Singapore, and over 26 million…

The Burden of Insomnia Insomnia is a highly prevalent and debilitating disorder associated with significant functional impairment. A Singapore study…

https://www.youtube.com/watch?v=XmPErFx4IjU Dr Leong Hoe Nam and Dr Ling Li Min, Infectious Disease Specialists from Rophi Clinic, Singapore, explains to us…

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…

Hypercholesterolemia is well-established major risk factor for atherosclerotic cardiovascular disease (ASCVD), along with others including hypertension, diabetes mellitus, chronic kidney…

Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease characterised by irreversible airflow limitation and associated with significant…

The IXORA trial is a head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis. Watch the video…

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products. Apart from new drugs and indications approval, HSA also…

Glaucoma is a prominent cause of irreversible blindness, with a global prevalence of 3.45% among individuals between 40-80 years of…